SPTX
Seaport Therapeutics, Inc.Company Information
- Company Name
- Seaport Therapeutics, Inc.
- CIK
- CIK0002042347
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- SPTX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SPTX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-22
- Last sale
- —
- Shares purchased (TTM)
- 1,113,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 36,166,148
- Shares outstanding
- 35,236,214
- Ownership
- 102.64%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 16.42%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock | 0 | 0 | ||||||
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 64 | 53 | ||||||
| Short Term Investments | 209 | 130 | ||||||
| Prepaid Expense And Other Assets Current | 9 | 6 | ||||||
| Assets Current | 282 | 188 | ||||||
| Property Plant And Equipment Net | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | ||||||
| Long Term Investments | 154 | 30 | ||||||
| Other Assets Noncurrent | 0 | 4 | ||||||
| Assets | 442 | 228 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 6 | 5 | ||||||
| Other Liabilities Current | 0 | 0 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 8 | 8 | ||||||
| Operating Lease Liability Current | 2 | 2 | ||||||
| Liabilities Current | 16 | 14 | ||||||
| Operating Lease Liability Noncurrent | 3 | 4 | ||||||
| Liabilities | 19 | 18 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | 325 | ||||||
Stockholders Equity | ||||||||
| Preferred Stock Value | 0 | - | ||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 625 | 24 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -202 | -140 | ||||||
| Stockholders Equity | 423 | -116 | ||||||
| Liabilities And Stockholders Equity | 442 | 228 | ||||||
| Temporary Equity Shares Authorized | - | 114 | ||||||
| Temporary Equity Shares Issued | - | 114 | ||||||
| Temporary Equity Shares Outstanding | - | 114 | ||||||
| Temporary Equity Liquidation Preference | - | 330 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 700 | 159 | ||||||
| Common Stock Shares Issued | 54 | 3 | ||||||
| Shares Outstanding | 54 | 3 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSeaport Therapeutics, Inc. (SPTX) — SEC Financial Statements & Analysis
Seaport Therapeutics, Inc. (SPTX) is a pharmaceutical preparations company, incorporated in DE. Seaport Therapeutics, Inc. trades on Nasdaq as: SPTX. Seaport Therapeutics, Inc. (SPTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, Seaport Therapeutics, Inc. carries a market cap of $765.33M, a P/B ratio of 1.81x, and an enterprise value of $701.11M. On the balance sheet, it maintains a current ratio of 18.00x, a quick ratio of 17.44x, working capital of $266.50M, a debt-to-equity ratio of 0.05x, a debt ratio of 0.04, and net debt of $-64.22M. Figures sourced from SEC EDGAR.
- Market Cap
- $765.33M
- P/B TTM
- 1.81x
- Debt To Equity
- 0.05x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Seaport Therapeutics, Inc. in?
Seaport Therapeutics, Inc. (SPTX) operates in the Pharmaceutical Preparations industry.
What exchange does SPTX trade on?
Seaport Therapeutics, Inc. (SPTX) trades on the Nasdaq.
Where is Seaport Therapeutics, Inc. incorporated?
Seaport Therapeutics, Inc. is incorporated in DE.
When was Seaport Therapeutics, Inc. (SPTX)'s most recent SEC filing?
Seaport Therapeutics, Inc. (SPTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is SPTX's market cap?
Seaport Therapeutics, Inc. (SPTX) has a market capitalization of $765.33M as of 2026-06-30.